Is In8bio Inc (INAB) overvalued? · $18.4M cap
In8bio Inc (INAB) is a biotechnology company listed on US.
This page asks whether In8bio Inc (INAB) looks expensive on cached numbers — not a short thesis.
No cached income statement for INAB, so there is no earnings base to call rich or cheap.
INAB currently screens at market cap $18.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next INAB 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the INAB stock page for the full model, not this heading.
Not investment advice.